09:20 AM EST, 03/07/2024 (MT Newswires) -- Andrew Cheng, Director, President and CEO, on March 04, 2024, sold 75,000 shares in Akero Therapeutics ( AKRO ) for $2,465,063. Following the Form 4 filing with the SEC, Cheng has control over a total of 591,416 shares of the company, with 591,416 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1744659/000095017024027510/xslF345X03/ownership.xml

Price: 29.77, Change: -0.23, Percent Change: -0.77